Results per Page:
Up in the Pol(II)s: hypertranscription predicts cancer outcomes
From the Henikoff Lab, Basic Sciences Division
Oxygen toxicity in worms: a chilling tale
From the Roth Lab, Basic Sciences Division
Donor factors influence success of fecal microbiota transplant
From the Rashidi Group, Pathogen Associated Malignancies Program of the Cancer Consortium and Clinical Research Division
COVID watchdawgs: SARS-CoV-2 at UW in the pandemic’s early days
From the Chu and Weil Labs, UW Medicine, in collaboration with the Cancer Basic Biology Program of the Cancer Consortium and Fred Hutch Vaccine and Infectious Disease Division
TEC specs: tumor endothelial cells in renal cell carcinoma
From the Akilesh Lab, UW Department of Laboratory Medicine & Pathology in collaboration with the Warren Lab, Translational Science and Therapeutics and Dr. Scott Tykodi, a clinical specialist for kidney cancer in the Clinical Research Division
Decisions, decisions: factors that impact HCT outcomes in AML
From the Walter Group, Translational Sciences and Therapeutics Division
Revaccination beliefs and behaviors in transplant survivors
From the UW School of Nursing in collaboration with the Long-Term Follow-Up Program, Clinical Research Division
Mutations remain one-in-a-million after HCT
From the Storb Group, Clinical Research Division
Driver’s ed: watching HSV co-infection and recombination in vivo
From the Jerome Lab, Vaccine & Infectious Disease Division
Anti-(idio)typical: a new immunogen to vaccinate against RSV
From the McGuire Lab, Vaccine & Infectious Disease Division